LiveRamp supplements proxy disclosures amid three stockholder suits over Publicis merger

LiveRamp Holdings, Inc.

Three stockholder suits filed (Garfield, O'Connor, Turner) allege misleading proxy statements; company denies merit.
Company voluntarily adds Evercore DCF and comps details; DCF implied equity value $33.83-$49.38 vs $38.50 merger consideration.
Evercore selected-comps analysis implied equity values $22.32-$46.21 across metrics; merger consideration $38.50 per share.
Projections: 2027E revenue $988M, pre-SBC adjusted EBITDA $271M; 2030E revenue $1,426M, pre-SBC EBITDA $451M.
Special meeting to vote on merger set for Aug 17, 2026; supplements aim to avoid delay from litigation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.